Evaluating the Utility of Existing Patient-Reported Outcome Scales in Novel Patient Populations with Pancreatic Cancer, Lung Cancer, and Myeloproliferative Neoplasms Using Medicare Current Beneficiary Survey Data
The Katz ADL, Rosow–Breslau IADL, and Nagi scales collected in the MCBS demonstrate acceptable internal consistency and test–retest reliability among patients with pancreatic cancer, lung cancer, and MPN, and are consistent with clinical worsening following diagnosis or hospitalization. These results suggest that using retrospective data may allow researchers to conduct preliminary assessments of existing PRO instruments in new populations of interest and generate useful exploratory disease information before embarking on de novo PRO development. </AbstractSection> Copyright The Author(s) 2013
Year of publication: |
2013
|
---|---|
Authors: | Ivanova, Jasmina ; Mytelka, Daniel ; Duh, Mei ; Birnbaum, Howard ; Cummings, Alice ; Roman, Alexandra San ; Price, Gregory ; Swindle, Ralph |
Published in: |
The Patient: Patient-Centered Outcomes Research. - Springer, ISSN 0889-048X. - Vol. 6.2013, 3, p. 189-200
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Duloxetine Use in Chronic Low Back Pain
Ivanova, Jasmina, (2012)
-
Pre-Diagnosis Excess Acute Care Costs in Alzheimer’s Patients among a US Medicaid Population
Geldmacher, David, (2013)
-
Rice, J., (2014)
- More ...